<DOC>
	<DOCNO>NCT00839319</DOCNO>
	<brief_summary>The purpose investigational study determine much male hormone , testosterone , necessary maintain sperm production testis . This knowledge use help development safe male hormonal contraception .</brief_summary>
	<brief_title>HOP-3 Manipulation Intratesticular Hormonal Milieu With Exogenous Testosterone</brief_title>
	<detailed_description>Three study drug use study : Testim ( testosterone gel ) , Human Chorionic Gonadotropin ( hCG ) acyline . Testosterone naturally occur hormone men . When give normal men , testosterone gel temporarily low amount testosterone testes low sperm count . hCG female hormone produce pregnancy similar action male hormone , luteinizing hormone ( LH ) . Like LH , hCG stimulates testis produce testosterone sperm , use treatment men deficient LH . When hCG give together testosterone normal men , amount testosterone testes change , dependent amount hCG receive . Some participant receive placebo hCG injection ( active medication ) . Acyline suppress LH ( luteinizing hormone ) FSH ( follicle stimulate hormone ) , hormone make pituitary gland brain , thus block signal brain cause testis make testosterone . Therefore , acyline block testosterone production . Men may experience side effect low level testosterone cause acyline . Acyline experimental drug . Testosterone gel hCG approve use men low testosterone level . The U.S. Food Drug Administration ( FDA ) allow testosterone gel , hCG acyline give combination research small number volunteer . Over 125 men receive acyline . Both Acyline hCG give injection . Acyline injection formulate subject weight may give multiple injection . Participation last approximately 2 month . The study involve minimum 9 visit Seattle , WA . Clinic visit Screening , Day 1 Day 10 take 1-1.5 hour . On Day 1 &amp; 10 fine needle aspiration one testis perform . The Day 7 , Day 17 , Day 40 visit take approximately 30 minute . The visit take 15 minute time . Over course study , include 5 separate blood draw , approximately 12 ounce ( one half cup ) blood drawn . Some study drug give injection . One drug topical gel . This NOT trial male contraceptive , study medication prevent pregnancy . Subjects must use acceptable form birth control .</detailed_description>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Males age 1850 Normal serum testosterone , LH FSH PSA &lt; 4.0 Agrees donate blood participate another research study study Informed consent In general good health base normal screen evaluation ( consist medical history , physical exam , normal sperm count , normal serum chemistry hematology ) Must willing use reliable form contraception study Oligospermia ( sperm count &lt; 15 million/mL 48 hour abstinence ) and/or abnormal motility morphology . Participation longterm male contraceptive study within past three month History testosterone anabolic steroid abuse past Poor general health significantly abnormal blood result History current testicular disease History bleeding disorder need anticoagulation History sleep apnea and/or major psychiatric problem BMI &gt; 32 Subjects skin condition might interfere exacerbate testosterone gel use Subject 's alcohol drug use</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>hCG</keyword>
	<keyword>testosterone</keyword>
	<keyword>Acyline</keyword>
	<keyword>Intratesticular hormone</keyword>
</DOC>